EMA proposes updating guideline for Alzheimer’s disease treatments

EMA proposes updating guideline for Alzheimer’s disease treatments | RAPS

Regulatory NewsChemistry, Manufacturing and Controls (CMC)Clinical TrialsEuropeEuropean Medicines Agency (EMA)PharmaceuticalsProduct developmentProduct LifecycleRegulatory Intelligence/PolicyRegulatory strategySubmission and registration

Continue Reading